Literature DB >> 2248514

Indomethacin responsive hypercalcaemia associated with a renal sarcoma.

J Gibbs1, M J Dillon, S Lang, S Meghji, J Pritchard.   

Abstract

An infant presented with a non-metastatic renal spindle cell sarcoma and hypercalcaemia, which resolved after treatment with indomethacin. There was in vivo and in vitro evidence that hypercalcaemia was mediated by circulatory prostaglandins.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2248514      PMCID： PMC1792356          DOI： 10.1136/adc.65.10.1168

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor. A study of 11 cases.

Authors:  A Leblanc; J M Caillaud; O Hartmann; C Kalifa; F Flamant; C Patte; M F Tournade; J Lemerle
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

2.  Congenital mesoblastic nephroma with hypercalcemia. Pathogenetic role of prostaglandins.

Authors:  L Vido; M Carli; G Rizzoni; L Calò; P Dalla Palma; A Parenti; F Fusco
Journal:  Am J Pediatr Hematol Oncol       Date:  1986

3.  A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy.

Authors:  D E Brenner; H A Harvey; A Lipton; L Demers
Journal:  Cancer       Date:  1982-02-01       Impact factor: 6.860

4.  Hypercalcemia associated with immunoreactive parathyroid hormone in a malignant rhabdoid tumor of the kidney (rhabdoid Wilms' tumor).

Authors:  L C Mayes; A G Kasselberg; J S Roloff; J N Lukens
Journal:  Cancer       Date:  1984-09-01       Impact factor: 6.860

Review 5.  The pathogenesis of humoral hypercalcaemia of malignancy.

Authors:  S H Ralston
Journal:  Lancet       Date:  1987-12-19       Impact factor: 79.321
  5 in total
  2 in total

Review 1.  renal tumors and tumor-like lesions in pediatric patients.

Authors:  J M Kissane; L P Dehner
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714

Review 2.  Paraneoplastic manifestations in children.

Authors:  J H de Graaf; R Y Tamminga; W A Kamps
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.